Actively Recruiting

Age: 18Years +
All Genders
Healthy Volunteers
ID07494864

Effects of Microbiological and Immunological Factors on the Lower Urinary Tract

Led by University of Zurich · Updated on 2026-03-27

800

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

U

University of Zurich

Lead Sponsor

K

Kessler Group

Collaborating Sponsor

AI-Summary

What this Trial Is About

Millions of people worldwide experience various urinary problems such as lower urinary tract dysfunction, bladder pain syndrome, urinary tract infections, and bladder cancer. This research aims to study the relationship between the bladder and the microbiome by looking at microbiological and immune factors and how they relate to lower urinary tract health in humans. The study is observational and led by the University of Zurich, focusing on different urinary conditions and healthy controls. Participants are divided into several groups based on their urinary health, including healthy individuals and those with different types of urinary tract infections, bladder pain, overactive bladder symptoms, and bladder cancer. The study involves collecting samples such as urine, vaginal or urethral swabs, rectal swabs, and blood. Participants also complete various questionnaires and keep diaries tracking their bladder and bowel habits over several days. During the study, participants will provide these samples and complete diaries and questionnaires to help researchers analyze clinical data and immune and microbiome markers for different urinary conditions. The main goal is to evaluate these differences over a one-year period. The study includes repeated sample collections and assessments, and participants will be monitored throughout this time to gather comprehensive information about their urinary health.

CONDITIONS

Brief Title

Effects of Microbiological and Immunological Factors on the Lower Urinary Tract

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Women and men aged 18 years or older
  • Able to give informed consent to participate
  • Willing to follow the study protocol throughout the trial
  • Willing to undergo repeated single catheterizations
  • Specific urinary conditions as defined for each study group: healthy controls; asymptomatic bacteriuria with or without catheter use; acute and recurrent urinary tract infections; chronic pelvic pain; overactive bladder symptoms; non-muscle-invasive bladder cancer
Not Eligible

You will not qualify if you...

  • Current or recent (last 21 days) antibiotic treatment except for certain UTI groups
  • Urinary tract infections caused by treatable conditions needing specific therapy
  • Therapies to prevent UTIs in the past 21 days except for certain UTI groups
  • Deterioration of upper urinary tract requiring medical intervention
  • Immunomodulatory or immunosuppressant therapies (with exceptions)
  • Congenital or acquired lower urinary tract malformations (healthy controls only)
  • Need for antiviral medication (healthy controls only)
  • Severe systemic diseases or active malignancy except bladder cancer
  • Unstable medical or psychiatric conditions posing risk
  • Drug or alcohol dependence in the past 6 months
  • Pregnancy or nursing
  • Inability to follow study procedures due to language or cognitive issues
  • Participation in other clinical trials within 4 weeks or as per local rules
  • Unconsciousness or hypersensitivity to related medicinal products

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Monitoring

Duration - 1 year

Participants undergo bio-sampling and complete various questionnaires and diaries to evaluate clinical, immunological, and biome markers related to lower urinary tract conditions.

Multiple visits for bio-sampling and assessments over 1 year

Trial Site Locations

Total: 1 location

1

Balgrist University Hospital

Zurich, Canton of Zurich, Switzerland, 8008

Actively Recruiting

Loading map...

Research Team

T

Thomas Kessler Kessler

L

Lorenz Leitner, PD Dr. med.

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

10

Similar Trials

A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-01...

Non-muscle-invasive Bladder Cancer

Actively Recruiting

17 locations

A Phase I Trial of Cancer-targeting Micelles for Non-myoinva...

Non-muscle-invasive Bladder Cancer

Actively Recruiting

1 location

A Multicenter, Randomized, Double-blind, Dose-parallel, Plac...

Chronic Pelvic Pain

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here